SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014)
SELLAS Life Sciences (SLS) reported Capital Leases of $17000.0 for Q3 2014, down 43.33% year-over-year from $30000.0 in Q3 2013, and down 10.53% quarter-over-quarter from $19000.0 in Q2 2014.
SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014) Analysis & Trends
SELLAS Life Sciences (SLS) has 5 years of Capital Leases data on file, last reported at $17000.0 in Q3 2014.
- Capital Leases for Q3 2014 came in at $17000.0, down 43.33% year-over-year; the trailing twelve-month figure through Sep 2014 was $17000.0 (down 43.33% YoY), and the FY2013 annual result was $26000.0, down 49.02% from the prior year.
- Capital Leases declined to $17000.0 in Q3 2014 per SLS's latest filing, from $19000.0 in the prior quarter.
- Over five years, Capital Leases peaked at $51000.0 in Q3 2012 and troughed at $10000.0 in Q2 2011.
- A 5-year average of $29571.4 and a median of $28000.0 in 2013 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2012 and 2014: Capital Leases surged 264.29% in 2012, then tumbled 54.9% in 2014.
- A 5-year view of Capital Leases shows it stood at $20000.0 in 2010, then surged by 60.0% to $32000.0 in 2011, then soared by 59.38% to $51000.0 in 2012, then sank by 49.02% to $26000.0 in 2013, then slumped by 34.62% to $17000.0 in 2014.
- Business Quant data shows SLS's Capital Leases at $17000.0 in Q3 2014, $19000.0 in Q2 2014, and $23000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 26,000.00 |
| Sep 30, 2013 | 30,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Mar 31, 2013 | 51,000.00 |
| Dec 31, 2012 | 51,000.00 |
| Sep 30, 2012 | 51,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 32,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 20,000.00 |